Literature DB >> 18087193

Microwave ablation of hepatocellular carcinoma.

Ping Liang1, Yang Wang.   

Abstract

OBJECTIVE: This article reviews the basic principles, equipment, current therapeutic status and future trends of microwave ablation (MWA) in the treatment of hepatocellular carcinoma (HCC).
METHODS: All articles published in English on MWA or MWA as a treatment for HCC were identified with a PubMed search from the 1990s through June 2007. Papers were reviewed on the technical advances of MWA equipment and the clinical applications of MWA including indications, techniques, therapeutic outcomes, complications and combination therapies.
RESULTS: MWA has several advantages, including high thermal efficiency, higher capability of coagulating blood vessels, faster ablation time, and an improved convention profile. MWA can induce large ablation volumes and yield good local tumor control, especially for small HCC. Larger HCC can also be completely ablated by using more effective antenna or simultaneous application of multiple antennae. Long-term survival comparable to that of surgery was obtained for tumors measuring 4 cm or less. Associated complications appear to be low.
CONCLUSIONS: MWA is a promising minimally invasive technique for the treatment of HCC. Future advances are warranted to improve the therapeutic efficacy. Copyright 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2007        PMID: 18087193     DOI: 10.1159/000111718

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  59 in total

Review 1.  Complications after percutaneous ablation of liver tumors: a systematic review.

Authors:  Eylon Lahat; Rony Eshkenazy; Alex Zendel; Barak Bar Zakai; Mayan Maor; Yael Dreznik; Arie Ariche
Journal:  Hepatobiliary Surg Nutr       Date:  2014-10       Impact factor: 7.293

2.  Electrode displacement strain imaging of thermally-ablated liver tissue in an in vivo animal model.

Authors:  N Rubert; S Bharat; R J DeWall; A Andreano; C Brace; J Jiang; L Sampson; T Varghese
Journal:  Med Phys       Date:  2010-03       Impact factor: 4.071

Review 3.  Tumor ablation and nanotechnology.

Authors:  Rachel L Manthe; Susan P Foy; Nishanth Krishnamurthy; Blanka Sharma; Vinod Labhasetwar
Journal:  Mol Pharm       Date:  2010-10-07       Impact factor: 4.939

Review 4.  Microwave ablation of hepatocellular carcinoma.

Authors:  Guido Poggi; Nevio Tosoratti; Benedetta Montagna; Chiara Picchi
Journal:  World J Hepatol       Date:  2015-11-08

Review 5.  Locoregional Therapy, Immunotherapy and the Combination in Hepatocellular Carcinoma: Future Directions.

Authors:  Meaghan S Dendy; Johannes M Ludwig; Stacey M Stein; Hyun S Kim
Journal:  Liver Cancer       Date:  2019-01-16       Impact factor: 11.740

6.  High-powered microwave ablation with a small-gauge, gas-cooled antenna: initial ex vivo and in vivo results.

Authors:  Meghan G Lubner; J Louis Hinshaw; Anita Andreano; Lisa Sampson; Fred T Lee; Christopher L Brace
Journal:  J Vasc Interv Radiol       Date:  2012-01-24       Impact factor: 3.464

7.  Percutaneous microwave ablation of liver cancer adjacent to the gastrointestinal tract.

Authors:  Pei Zhou; Ping Liang; Xiaoling Yu; Yang Wang; Baowei Dong
Journal:  J Gastrointest Surg       Date:  2008-09-30       Impact factor: 3.452

8.  Laparoscopic microwave ablation in patients with hepatocellular carcinoma: a prospective cohort study.

Authors:  Umberto Cillo; Giulia Noaro; Alessandro Vitale; Daniele Neri; Francesco D'Amico; Enrico Gringeri; Fabio Farinati; Valter Vincenzi; Mario Vigo; Giacomo Zanus
Journal:  HPB (Oxford)       Date:  2014-04-18       Impact factor: 3.647

Review 9.  Advances in managing hepatocellular carcinoma.

Authors:  Marielle Reataza; David K Imagawa
Journal:  Front Med       Date:  2014-05-08       Impact factor: 4.592

10.  Simultaneous microwave coagulo-necrotic therapy (MCN) and laparoscopic splenectomy for the treatment of hepatocellular carcinoma with cirrhotic hypersplenism.

Authors:  Tomoki Ryu; Yuko Takami; Norifumi Tsutsumi; Masaki Tateishi; Kazuhiro Mikagi; Yoshiyuki Wada; Hideki Saitsu
Journal:  Surg Today       Date:  2016-08-30       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.